Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I: A descriptive pilot study

Supportive Care in Cancer

Volumn 4, Issue 2, 1996, Pages 118-128

  Fosså, Sophie D ^a   Moynihan, Clare ^b   Serbouti, Said ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c EORTC DATA CENTER   (Belgium)

Author keywords

Doctors' and patients' assessment; Long term psychosocial and physical morbidity; Testicular cancer stage I

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; NORWAY; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PILOT STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SOCIAL ADAPTATION; TESTIS TUMOR; UNITED KINGDOM;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; DATA COLLECTION; DISEASE-FREE SURVIVAL; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NORWAY; PHYSICIAN'S ROLE; PILOT PROJECTS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SOCIAL ADJUSTMENT; TESTICULAR NEOPLASMS;

EID: 0030095675     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01845761     Document Type: Article

References (31)

1. Aaronson NK (1991) Methodological issues in assessing the quality of life of cancer patients. Cancer 67:844-850
2. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Fletcher H, Fleishman SB, Haes JCJM de, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
3. Bergman B, Sullivan M, Sorenson S (1992) Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncol 31:19-28
4. Boyer M, Raghavan D (1992) Toxicity of treatment of germ cell tumors. Semin Oncol 19:128-142
5. Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, Kennealey GT. members of the Zoladex Prostate Cancer Study Group (1992) Quality of life and psychological status in stase D prostate cancer. Quality Life Res 1:323-330
6. Cullen MH, Cook J, Woodroffe C, Murphy A, Warwick J, Ferry D (1994) Surveillance or immediate adjuvant chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT). Br J Cancer 69 [Suppl 21]: 14
7. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. Urology 149:237-243
8. Douchez J, Droz JP, Desclaux B, Allain Y, Fargeot P, Caty A, Charrot P (1993) Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. Urology 149:498-501
9. Fallowfield L (1990) The quality of life. The missing measurement in health care. Methodological issues. (Human horizon series) Souvenir Press, London, pp 43-44
10. Feldstein ML (1991) Quality-of-life-adjusted survival for comparing cancer treatments. A commentarv on TWiST and Q-TWiST. Cancer 67:851-854
11. Fernandez C, Rosell R, Abad-Esteve A, Monras P, Moreno I, Serichol M, Roviralta M (1989) Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol 28:29-33
12. Finkelstein DM, Cassileth BR, Bonomi PD, et al (1988) A pilot study of the Functional Living Index-Cancer (FLIC). Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630-633
13. Fosså SD, Aass N, Kaalhus O (1989) Radiotherapy for testicular seminoma stage I. Treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16:383-388
14. Fosså SD, Aaronson NK, Newling D, Cangh PJ van, Denis L, Kurth K-H, Pauw M de, members of the EORTC GU Group (1990) Subjective response to treatment of hormone-resistant metastatic prostatic cancer. Eur J Cancer Clin Oncol 26:1133-1136
15. Fosså SD, Jacobsen A-B, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Øgreid P, Borge L, Urnes T, Bjerklund-Johansen T (1994) How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited CT resources? Br J Cancer 74:652-658
16. Ganz PA, Haskell CM, Figlin RA, La Soto N, Siau J, for the UCLA Solid Tumor Group (1988) Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky Performance Status and the Functional Living Index-Cancer. Cancer 61:849-856
17. Haes JC de, Knippenberg FC van, Neut JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038
18. Kaasa S, Aass N, Mastekaasa A, Lund E, Fosså SD (1991) Psychosocial well-being in testicular cancer patients. Eur J Cancer 27:1091-1095
19. Kiebert GM, Haes JC de, Velde CJ van de (1991) The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients. A review. J Clin Oncol 9:1059-1070
20. Maunsell E, Brisson J, Deschênes L (1992) Psychological distress after initial treatment of breast cancer. Cancer 70:120-125
21. Moynihan C (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 6:477-510
22. O'Youg J, McPeek B (1987) Quality of life variables in surgical trials. J Chronic Dis 40:513-522
23. Parliament MB, Danjoux CE, Clayton T (1985) Is cancer treatment toxicity accurately reported? Int J Radiat Oncol Biol Phys 11:603-608
24. Parmar H, Phillips RH, Lightman SL, Edwards L (1988) How would you like to have an orchidectomy for advanced prostatic cancer? Am J Clin Oncol 11:160-168
25. Pont J. Höltl W, Kosak D, Machacek E, Kienzer H, Julcher H, Honetz N (1990) Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 8:16-20
26. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, Cook PA, for the Medical Research Council Testicular Tumors Working Party (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10:1762-1768
27. Rieker PP, Fitzegerald EM, Kalish LA (1990) Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8:347-355
28. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-122
29. Smart CR, Yates JW (1987) Quality of life. Cancer 60:620-622
30. Sprangers MAG, Cull A, Bjordal K, Groenvoid M, Aaronson NK, for the EORTC Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Quality Life Res 2:287-295
31. Tannock IF, Gospodarowicz M, Meakin W, et al (1989) Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 7:590-597